Top

Published in:

01-05-2021 | Obesity | Review

Hypothalamic glucose-sensing mechanisms

Authors: Nal Ae Yoon, Sabrina Diano

Published in: Diabetologia | Issue 5/2021

Abstract

Chronic metabolic diseases, including diabetes and obesity, have become a major global health threat of the twenty-first century. Maintaining glucose homeostasis is essential for survival in mammals. Complex and highly coordinated interactions between glucose-sensing mechanisms and multiple effector systems are essential for controlling glucose levels in the blood. The central nervous system (CNS) plays a crucial role in regulating glucose homeostasis. Growing evidence indicates that disruption of glucose sensing in selective CNS areas, such as the hypothalamus, is closely interlinked with the pathogenesis of obesity and type 2 diabetes mellitus. However, the underlying intracellular mechanisms of glucose sensing in the hypothalamus remain elusive. Here, we review the current literature on hypothalamic glucose-sensing mechanisms and discuss the impact of alterations of these mechanisms on the pathogenesis of diabetes.

Graphical abstract

Available only for authorised users

Czech MP (2017) Insulin action and resistance in obesity and type 2 diabetes. Nat Med 23(7):804–814. https://doi.org/10.1038/nm.4350CrossRefPubMedPubMedCentral

Roder PV, Wu B, Liu Y, Han W (2016) Pancreatic regulation of glucose homeostasis. Exp Mol Med 48:e219. https://doi.org/10.1038/emm.2016.6CrossRefPubMedPubMedCentral

Ritter S (2017) Monitoring and maintenance of brain glucose supply importance of hindbrain catecholamine neurons in this multifaceted task. In: Harris RBS (ed) Appetite and food intake: Central control, 2nd edn. CRC Press/Taylor & Francis, Boca Raton, pp 177–204CrossRef

Timper K, Bruning JC (2017) Hypothalamic circuits regulating appetite and energy homeostasis: Pathways to obesity. Dis Model Mech 10(6):679–689. https://doi.org/10.1242/dmm.026609CrossRefPubMedPubMedCentral

Routh VH (2010) Glucose sensing neurons in the ventromedial hypothalamus. Sensors 10(10):9002–9025. https://doi.org/10.3390/s101009002CrossRefPubMed

Gao Q, Horvath TL (2008) Neuronal control of energy homeostasis. FEBS Lett 582(1):132–141. https://doi.org/10.1016/j.febslet.2007.11.063CrossRefPubMed

Varela L, Horvath TL (2012) Leptin and insulin pathways in POMC and AgRP neurons that modulate energy balance and glucose homeostasis. EMBO Rep 13(12):1079–1086. https://doi.org/10.1038/embor.2012.174CrossRefPubMedPubMedCentral

Schwartz MW, Woods SC, Porte D Jr, Seeley RJ, Baskin DG (2000) Central nervous system control of food intake. Nature 404(6778):661–671. https://doi.org/10.1038/35007534CrossRefPubMed

Nijenhuis WA, Oosterom J, Adan RA (2001) AgRP(83-132) acts as an inverse agonist on the human-melanocortin-4 receptor. Mol Endocrinol 15(1):164–171. https://doi.org/10.1210/mend.15.1.0578CrossRefPubMed

10.

Mountjoy PD, Bailey SJ, Rutter GA (2007) Inhibition by glucose or leptin of hypothalamic neurons expressing neuropeptide Y requires changes in AMP-activated protein kinase activity. Diabetologia 50(1):168–177. https://doi.org/10.1007/s00125-006-0473-3CrossRefPubMed

11.

Fioramonti X, Contie S, Song Z, Routh VH, Lorsignol A, Penicaud L (2007) Characterization of glucosensing neuron subpopulations in the arcuate nucleus: Integration in neuropeptide Y and pro-opio melanocortin networks? Diabetes 56(5):1219–1227. https://doi.org/10.2337/db06-0567

12.

Murphy BA, Fioramonti X, Jochnowitz N et al (2009) Fasting enhances the response of arcuate neuropeptide Y-glucose-inhibited neurons to decreased extracellular glucose. Am J Physiol Cell Physiol 296(4):C746–C756. https://doi.org/10.1152/ajpcell.00641.2008CrossRefPubMedPubMedCentral

13.

Ruud J, Steculorum SM, Bruning JC (2017) Neuronal control of peripheral insulin sensitivity and glucose metabolism. Nat Commun 8:15259. https://doi.org/10.1038/ncomms15259CrossRefPubMedPubMedCentral

14.

Konner AC, Janoschek R, Plum L et al (2007) Insulin action in AgRP-expressing neurons is required for suppression of hepatic glucose production. Cell Metab 5(6):438–449. https://doi.org/10.1016/j.cmet.2007.05.004CrossRefPubMed

15.

Steculorum SM, Ruud J, Karakasilioti I et al (2016) AgRP neurons control systemic insulin sensitivity via myostatin expression in brown adipose tissue. Cell 165(1):125–138. https://doi.org/10.1016/j.cell.2016.02.044CrossRefPubMedPubMedCentral

16.

Pozo M, Claret M (2018) Hypothalamic control of systemic glucose homeostasis: The pancreas connection. Trends Endocrinol Metab 29(8):581–594. https://doi.org/10.1016/j.tem.2018.05.001CrossRefPubMed

17.

Ibrahim N, Bosch MA, Smart JL et al (2003) Hypothalamic proopiomelanocortin neurons are glucose responsive and express K_ATP channels. Endocrinology 144(4):1331–1340. https://doi.org/10.1210/en.2002-221033CrossRefPubMed

18.

Parton LE, Ye CP, Coppari R et al (2007) Glucose sensing by POMC neurons regulates glucose homeostasis and is impaired in obesity. Nature. 449(7159):228–232. https://doi.org/10.1038/nature06098CrossRefPubMed

19.

Chretien C, Fenech C, Lienard F et al (2017) Transient receptor potential canonical 3 (TRPC3) channels are required for hypothalamic glucose detection and energy homeostasis. Diabetes 66(2):314–324. https://doi.org/10.2337/db16-1114CrossRefPubMed

20.

Wai T, Langer T (2016) Mitochondrial dynamics and metabolic regulation. Trends Endocrinol Metab 27(2):105–117. https://doi.org/10.1016/j.tem.2015.12.001CrossRefPubMed

21.

Ramirez S, Gomez-Valades AG, Schneeberger M et al (2017) Mitochondrial dynamics mediated by Mitofusin 1 is required for POMC neuron glucose-sensing and insulin release control. Cell Metab 25(6):1390–1399 e6. https://doi.org/10.1016/j.cmet.2017.05.010CrossRefPubMed

22.

Jin S, Diano S (2018) Mitochondrial dynamics and hypothalamic regulation of metabolism. Endocrinology 159(10):3596–3604. https://doi.org/10.1210/en.2018-00667CrossRefPubMedPubMedCentral

23.

Santoro A, Campolo M, Liu C et al (2017) DRP1 suppresses leptin and glucose sensing of POMC neurons. Cell Metab 25(3):647–660. https://doi.org/10.1016/j.cmet.2017.01.003CrossRefPubMedPubMedCentral

24.

Hennings TG, Chopra DG, DeLeon ER et al (2018) In vivo deletion of beta-cell Drp1 impairs insulin secretion without affecting islet oxygen consumption. Endocrinology. 159(9):3245–3256. https://doi.org/10.1210/en.2018-00445CrossRefPubMedPubMedCentral

25.

Stanley SA, Kelly L, Latcha KN et al (2016) Bidirectional electromagnetic control of the hypothalamus regulates feeding and metabolism. Nature 531(7596):647–650. https://doi.org/10.1038/nature17183CrossRefPubMedPubMedCentral

26.

Tong Q, Ye C, McCrimmon RJ et al (2007) Synaptic glutamate release by ventromedial hypothalamic neurons is part of the neurocircuitry that prevents hypoglycemia. Cell Metab 5(5):383–393. https://doi.org/10.1016/j.cmet.2007.04.001CrossRefPubMedPubMedCentral

27.

McCrimmon RJ, Fan X, Cheng H et al (2006) Activation of AMP-activated protein kinase within the ventromedial hypothalamus amplifies counterregulatory hormone responses in rats with defective counterregulation. Diabetes 55(6):1755–1760. https://doi.org/10.2337/db05-1359CrossRefPubMed

28.

Murphy BA, Fakira KA, Song Z, Beuve A, Routh VH (2009) AMP-activated protein kinase and nitric oxide regulate the glucose sensitivity of ventromedial hypothalamic glucose-inhibited neurons. Am J Physiol Cell Physiol 297(3):C750–C758. https://doi.org/10.1152/ajpcell.00127.2009CrossRefPubMedPubMedCentral

29.

Chan O, Cheng H, Herzog R et al (2008) Increased GABAergic tone in the ventromedial hypothalamus contributes to suppression of counterregulatory responses after antecedent hypoglycemia. Diabetes 57(5):1363–1370. https://doi.org/10.2337/db07-1559

30.

Toda C, Kim JD, Impellizzeri D, Cuzzocrea S, Liu ZW, Diano S (2016) UCP2 regulates mitochondrial fission and ventromedial nucleus control of glucose responsiveness. Cell. 164(5):872–883. https://doi.org/10.1016/j.cell.2016.02.010CrossRefPubMedPubMedCentral

31.

Pellerin L, Magistretti PJ (2004) Neuroscience. Let there be (NADH) light. Science 305(5680):50–52. https://doi.org/10.1126/science.1100428CrossRefPubMed

32.

Harris AL (2007) Connexin channel permeability to cytoplasmic molecules. Prog Biophys Mol Biol 94(1–2):120–143. https://doi.org/10.1016/j.pbiomolbio.2007.03.011CrossRefPubMedPubMedCentral

33.

Sohl G, Willecke K (2004) Gap junctions and the connexin protein family. Cardiovasc Res 62(2):228–232. https://doi.org/10.1016/j.cardiores.2003.11.013CrossRefPubMed

34.

Allard C, Carneiro L, Grall S et al (2014) Hypothalamic astroglial connexins are required for brain glucose sensing-induced insulin secretion. J Cereb Blood Flow Metab 34(2):339–346. https://doi.org/10.1038/jcbfm.2013.206CrossRefPubMed

35.

Garcia-Caceres C, Quarta C, Varela L et al (2016) Astrocytic insulin signaling couples brain glucose uptake with nutrient availability. Cell 166(4):867–880. https://doi.org/10.1016/j.cell.2016.07.028CrossRefPubMed

36.

Belanger M, Allaman I, Magistretti PJ (2011) Brain energy metabolism: Focus on astrocyte-neuron metabolic cooperation. Cell Metab 14(6):724–738. https://doi.org/10.1016/j.cmet.2011.08.016CrossRefPubMed

37.

Ainscow EK, Mirshamsi S, Tang T, Ashford ML, Rutter GA (2002) Dynamic imaging of free cytosolic ATP concentration during fuel sensing by rat hypothalamic neurones: Evidence for ATP-independent control of ATP-sensitive K⁺ channels. J Physiol 544(2):429–445. https://doi.org/10.1113/jphysiol.2002.022434CrossRefPubMedPubMedCentral

38.

Song Z, Routh VH (2005) Differential effects of glucose and lactate on glucosensing neurons in the ventromedial hypothalamic nucleus. Diabetes 54(1):15–22. https://doi.org/10.2337/diabetes.54.1.15

39.

Lam TK, Gutierrez-Juarez R, Pocai A et al (2007) Brain glucose metabolism controls the hepatic secretion of triglyceride-rich lipoproteins. Nat Med 13(2):171–180. https://doi.org/10.1038/nm1540CrossRefPubMed

40.

Abraham MA, Rasti M, Bauer PV, Lam TKT (2018) Leptin enhances hypothalamic lactate dehydrogenase A (LDHA)-dependent glucose sensing to lower glucose production in high-fat-fed rats. J Biol Chem 293(11):4159–4166. https://doi.org/10.1074/jbc.RA117.000838CrossRefPubMedPubMedCentral

41.

Elizondo-Vega R, Cortes-Campos C, Barahona MJ, Oyarce KA, Carril CA, Garcia-Robles MA (2015) The role of tanycytes in hypothalamic glucosensing. J Cell Mol Med 19(7):1471–1482. https://doi.org/10.1111/jcmm.12590CrossRefPubMedPubMedCentral

42.

Elizondo-Vega RJ, Recabal A, Oyarce K (2019) Nutrient sensing by hypothalamic tanycytes. Front Endocrinol 10:244. https://doi.org/10.3389/fendo.2019.00244CrossRef

43.

Sanders NM, Dunn-Meynell AA, Levin BE (2004) Third ventricular alloxan reversibly impairs glucose counterregulatory responses. Diabetes 53(5):1230–1236. https://doi.org/10.2337/diabetes.53.5.1230CrossRefPubMed

44.

Yoo S, Cha D, Kim S et al (2020) Tanycyte ablation in the arcuate nucleus and median eminence increases obesity susceptibility by increasing body fat content in male mice. Glia 68(10):1987–2000. https://doi.org/10.1002/glia.23817CrossRefPubMed

45.

de Andrade IS, Zemdegs JC, de Souza AP et al (2015) Diet-induced obesity impairs hypothalamic glucose sensing but not glucose hypothalamic extracellular levels, as measured by microdialysis. Nutr Diabetes 5:e162. https://doi.org/10.1038/nutd.2015.12CrossRefPubMedPubMedCentral

46.

Ashford ML, Boden PR, Treherne JM (1990) Glucose-induced excitation of hypothalamic neurones is mediated by ATP-sensitive K+ channels. Pflugers Arch 415(4):479–483. https://doi.org/10.1007/BF00373626CrossRefPubMed

47.

Taylor R (2012) Insulin resistance and type 2 diabetes. Diabetes 61(4):778–779. https://doi.org/10.2337/db12-0073

48.

Magnan C, Levin BE, Luquet S (2015) Brain lipid sensing and the neural control of energy balance. Mol Cell Endocrinol 418(Pt 1):3–8. https://doi.org/10.1016/j.mce.2015.09.019CrossRefPubMed

49.

Wilcox G (2005) Insulin and insulin resistance. Clin Biochem Rev 26(2):19–39PubMedPubMedCentral

50.

Thaler JP, Yi CX, Schur EA et al (2012) Obesity is associated with hypothalamic injury in rodents and humans. J Clin Invest 122(1):153–162. https://doi.org/10.1172/JCI59660CrossRefPubMed

51.

Kim JD, Yoon NA, Jin S, Diano S (2019) Microglial UCP2 mediates inflammation and obesity induced by high-fat feeding. Cell Metab 30(5):952–962 e5. https://doi.org/10.1016/j.cmet.2019.08.010CrossRefPubMedPubMedCentral

52.

Diggs-Andrews KA, Zhang X, Song Z, Daphna-Iken D, Routh VH, Fisher SJ (2010) Brain insulin action regulates hypothalamic glucose sensing and the counterregulatory response to hypoglycemia. Diabetes 59(9):2271–2280. https://doi.org/10.2337/db10-0401

53.

Dunn-Meynell AA, Routh VH, Kang L, Gaspers L, Levin BE (2002) Glucokinase is the likely mediator of glucosensing in both glucose-excited and glucose-inhibited central neurons. Diabetes 51(7):2056–2065. https://doi.org/10.2337/diabetes.51.7.2056

54.

Osundiji MA, Evans ML (2011) Hypothalamic glucose sensing and glycaemic disease. Curr Diabetes Rev 7(2):84–98. https://doi.org/10.2174/157339911794940701CrossRefPubMed

55.

van de Ven KC, van der Graaf M, Tack CJ, Heerschap A, de Galan BE (2012) Steady-state brain glucose concentrations during hypoglycemia in healthy humans and patients with type 1 diabetes. Diabetes 61(8):1974–1977. https://doi.org/10.2337/db11-1778CrossRefPubMedPubMedCentral

56.

Cranston I, Reed LJ, Marsden PK, Amiel SA (2001) Changes in regional brain ¹⁸F-fluorodeoxyglucose uptake at hypoglycemia in type 1 diabetic men associated with hypoglycemia unawareness and counter-regulatory failure. Diabetes 50(10):2329–2336. https://doi.org/10.2337/diabetes.50.10.2329

57.

Bingham EM, Dunn JT, Smith D et al (2005) Differential changes in brain glucose metabolism during hypoglycaemia accompany loss of hypoglycaemia awareness in men with type 1 diabetes mellitus. An [¹¹C]-3-O-methyl-D-glucose PET study. Diabetologia 48(10):2080–2089. https://doi.org/10.1007/s00125-005-1900-6

Title: Hypothalamic glucose-sensing mechanisms
Authors: Nal Ae Yoon
Sabrina Diano
Publication date: 01-05-2021
Publisher: Springer Berlin Heidelberg
Keywords: Obesity
Obesity
Insulins
Hypoglycemia
Insulins
Published in: Diabetologia / Issue 5/2021
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI: https://doi.org/10.1007/s00125-021-05395-6

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

At a glance: The STEP trials

Springer Medicine

Abstract

Graphical abstract

Please log in to get access to this content

Other articles of this Issue 5/2021

The promise of stem cell-derived islet replacement therapy

Saturated fatty acids entrap PDX1 in stress granules and impede islet beta cell function

Consequences of recurrent hypoglycaemia on brain function in diabetes

Transforming type 1 diabetes: the next wave of innovation

Minimising hypoglycaemia in the real world: the challenge of insulin

Up Front

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage